METTL14 modulates the autophagy-pyroptosis pathway in fibroblasts by modifying BECN1 through m6A methylation to promote wound healing in DFUs and SYD treatment
METTL14 moduliert in Fibroblasten den Autophagie-Pyroptose-Weg durch m6A-Methylierung von BECN1 und fördert die Wundheilung bei DFUs und unter SYD-Behandlung
Cell Biology and Toxicology · 01.05.2026 · 42 (1)
DOI: 10.1007/s10565-026-10196-x ↗Auf einen Blick
In Zell- und Tiermodellen für diabetische Fußulzera war METTL14 mit Autophagie, Pyroptose, Angiogenese und Wundheilung verbunden. SYD erhöhte METTL14 und verbesserte diese Parameter.
Fragestellung
Welche Rolle spielt METTL14 bei der Wundheilung von DFUs unter SYD-Behandlung und über welchen Mechanismus wirkt es?
Methode
qPCR und Western Blot; DFU-Rattenmodelle und Fibroblasten unter hohem Glukosegehalt; Verlust- und Gewinnfunktionsassays; MeRIP- und RNA-Stabilitätsassays; Untersuchung von SYD.
Ergebnisse
Hohe Glukose senkte METTL14, verringerte Vitalität, Migration und Autophagie und erhöhte Pyroptose. METTL14-Überexpression stabilisierte BECN1-mRNA, verbesserte Angiogenese und beschleunigte die Wundheilung; SYD zeigte ähnliche Effekte.
Schlussfolgerung der Autor:innen
METTL14-vermittelte m6A-Modifikation von BECN1 beeinflusst Autophagie, Pyroptose und Angiogenese und verbessert die Wundheilung bei DFUs. METTL14 ist ein zentraler Regulator der SYD-vermittelten Wundreparatur.
Kernaussagen
- Hohe Glukose senkte METTL14 in Fibroblasten.
- METTL14 stabilisierte BECN1-mRNA über m6A-Modifikation.
- SYD erhöhte METTL14 und förderte Wundschluss und Angiogenese.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology and Toxicology, online erschienen am 01.05.2026. Verfasst von Zhaowei Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China. Hauptthemen laut MEDLINE: Autophagy, Beclin-1, Diabetic Foot, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qingdao Medical and Healthcare Research Program, Shandong Traditional Chinese Medicine Science and Technology Program.
Themen: Wundversorgung
Abstract (Originalsprache)
Background
Diabetic foot ulcers (DFUs) are prevalent complication in diabetes. METTL14 serves as a key regulator of both autophagy and pyroptosis, both essential for the healing of DFUs. Simiao Yong'an Decoction (SYD) has demonstrated potential in promoting skin wound healing. This study investigates how METTL14 functions as a main regulator in DFU wound healing during SYD treatment and explores the underlying mechanisms.
Methods
Both qPCR and western blot assays were performed to determine METTL14 and BECN1 expression. DFU rat models and fibroblasts stimulated with high glucose (HG) were used to evaluate the role of METTL14 in autophagy, pyroptosis, pro-angiogenic ability, and wound healing through both loss- and gain-of-function assays. The association between METTL14 and BECN1 was examined via MeRIP and RNA stability assays. Futhermore, the therapeutic effects of SYD on DFUs were assessed.
Results
Exposure to HG reduced METTL14 levels in fibroblasts, resulting in reduced cell viability and migration, lowered autophagy, and increased pyroptosis. Increasing METTL14 expression reversed these cellular impairments and enhanced angiogenesis driven by fibroblasts. Mechanistically, METTL14 stabilized BECN1 mRNA via m 6 A modification. In a rodent DFU model, overexpression of METTL14 accelerated wound healing, improved angiogenesis, and regulated autophagy and pyroptosis; these beneficial effects were partially reversed when BECN1 was knocked down. Furthermore, treatment with SYD increased METTL14 expression, promoted wound closure, angiogenesis, and autophagy, while reducing pyroptosis; these positive outcomes were significantly reduced when METTL14 was knocked down.
Conclusions
METTL14-mediated m 6 A modification of BECN1 influences autophagy, pyroptosis, and angiogenesis to enhance wound healing in DFUs. METTL14 serves as a key regulator in SYD-mediated wound repair, offering a novel therapeutic strategy for treating DFUs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, 266003, China.
- Department of Vascular Surgery, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), No.4, Renmin Road, Qingdao, 266033, Shandong Province, P. R. China.
- Department of Vascular Surgery, Qingdao Hiser Hospital Affiliated of Qingdao University (Qingdao Traditional Chinese Medicine Hospital), No.4, Renmin Road, Qingdao, 266033, Shandong Province, P. R. China. liqiang_2024@1…
Förderung
- Qingdao Medical and Healthcare Research Program
- Shandong Traditional Chinese Medicine Science and Technology Program
Zitieren
APA
Wang, Z., Wei, Z., Yu, Q., Wang, L., Liu, K., Wang, H., & Li, Q. (2026). METTL14 modulates the autophagy-pyroptosis pathway in fibroblasts by modifying BECN1 through m6A methylation to promote wound healing in DFUs and SYD treatment. Cell Biology and Toxicology, 42(1). https://doi.org/10.1007/s10565-026-10196-x
Vancouver
Wang Z, Wei Z, Yu Q, Wang L, Liu K, Wang H, et al. METTL14 modulates the autophagy-pyroptosis pathway in fibroblasts by modifying BECN1 through m6A methylation to promote wound healing in DFUs and SYD treatment. Cell Biology and Toxicology. 2026;42(1). doi:10.1007/s10565-026-10196-x
BibTeX
@article{Wang2026,
author = {Wang, Zhaowei and Wei, Zongqiang and Yu, Qinyao and Wang, Linru and Liu, Kai and Wang, Hongjie and Li, Qiang},
title = {METTL14 modulates the autophagy-pyroptosis pathway in fibroblasts by modifying BECN1 through m6A methylation to promote wound healing in DFUs and SYD treatment},
journal = {Cell Biology and Toxicology},
year = {2026},
volume = {42},
number = {1},
doi = {10.1007/s10565-026-10196-x}
}
EUVIMED